Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Fidgetin interacting with microtubule end binding protein EB3 affects axonal regrowth in spinal cord injury

Fidgetin interacting with microtubule end binding protein EB3 affects axonal regrowth in spinal cord injury

Neural Regeneration Research, 2023 · DOI: 10.4103/1673-5374.373716 · Published: December 1, 2023

Spinal Cord InjuryRegenerative MedicineNeurology

Simple Explanation

This study investigates how a protein called fidgetin affects the regrowth of nerve fibers (axons) after spinal cord injury. Fidgetin is an enzyme that cuts microtubules, which are essential for axon growth and movement. The researchers found that depleting fidgetin promotes axon regeneration after spinal cord injury, while also increasing the expression of a protein called end binding protein 3 (EB3). The study suggests that fidgetin can be a target for new therapies to promote axon regeneration after spinal cord injury, revealing a mechanism by which fidgetin cuts specific microtubules.

Study Duration
28 days
Participants
36 adult male Sprague-Dawley rats, E18 rat cortical neurons, primary astrocytes
Evidence Level
Not specified

Key Findings

  • 1
    Depletion of fidgetin enhances axon regeneration after spinal cord injury and increases the expression of end binding protein 3 (EB3).
  • 2
    Fidgetin interacts with EB3 and trims tyrosinated tubulins, which are components of microtubules, thereby affecting axonal regrowth and branching.
  • 3
    Fign depletion enables greater amounts of Tyr-tubulin to break through the T-zone into the P-domain.

Research Summary

This study investigates the role of fidgetin (Fign), a microtubule-severing enzyme, in axonal regeneration after spinal cord injury (SCI). The researchers found that depleting Fign enhances axon regeneration and increases the expression of end-binding protein 3 (EB3). The study reveals that Fign interacts with EB3 and trims tyrosinated tubulins, affecting axonal regrowth and branching. Fign knockdown improved BBB score, which reached significance on the 14th day post-injury The findings suggest that Fign can be a novel therapeutic target to promote axonal regeneration after spinal cord injury, revealing an innovative mechanism by which Fign preferentially severs labile microtubules.

Practical Implications

Therapeutic Target

Fidgetin can be used as a novel therapeutic target to promote axonal regeneration after spinal cord injury.

Drug Development

The Fign/EB3 interaction can be targeted for drug development to facilitate axon regeneration and functional recovery after SCI.

Clinical Translation

Fidgetin knockdown is beneficial to the recovery of spinal cord injury and might be a potential therapeutic target.

Study Limitations

  • 1
    Female rats were excluded from the in vivo study to avoid the effects of estrogen.
  • 2
    Whether other molecules exist in the Fign/EB3 complex remains to be studied.
  • 3
    Not specified

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury